Showing results (1871-1880 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|May 10, 2015
Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk StratificationJun Li, Qing Wang, Zhengqing Lei, et al.
The Oncologist|April 19, 2015
A phase ib study of safety and pharmacokinetics of ramucirumab in combination with paclitaxel in patients with advanced gastric adenocarcinomasShinya Ueda, Taroh Satoh, Masahiro Gotoh, et al.
The Oncologist|August 25, 2025
Clinicopathological and molecular characteristics and treatment outcomes of SMARCA4-deficient thoracic tumors: A comprehensive analysisYing Liu, Fangfang Liu, Chengyan Wang, et al.
The Oncologist|July 25, 2016
Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid TumorsRalf-Dieter Hofheinz, Gaël Deplanque, Yoshito Komatsu, et al.
The Oncologist|August 25, 2025
Predictors of outcomes in advanced non-small cell lung cancer treated with pembrolizumab maintenanceVamsidhar Velcheti, Xuezheng Sun, Maya Hanna, et al.
The Oncologist|July 10, 2015
Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the LiteratureBarbara Kiesewetter, Andrés J M Ferreri, Markus Raderer
The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.
The Oncologist|August 4, 2016
Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma PatientsLetizia Gandolfi, Cinzia Pellegrini, Beatrice Casadei, et al.
The Oncologist|August 4, 2016
Analysis of Real-World Data on Overall Survival in Multiple Myeloma Patients With ≥3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiDSaad Usmani, Tahamtan Ahmadi, Yvette Ng, et al.
The Oncologist|September 2, 2025
Outcomes of Palliative Porto-Mesenteric Venous Stenting in Unresectable Pancreatic MalignanciesStella Konadu Adjei Antwi, Andrea Zironda, Alessandro Fogliati, et al.
Pageof 571